Company news_innoModel-Provide preclinical pharmacological services

Cn /En

News Center

——

Company news

Industry news

02-29

InnoModels: Introduction of iHuPBMC-NK Platform

In today's rapid development of biotechnology, immunotherapy has become an important means of cancer treatment. In this field, the iHuPBMC-NK platform of InnoModels Biotechnology has attracted extensive attention from the industry due to its unique advantages and features. In this paper, we will introduce the features of iHuPBMC-NK platform in detail and look forward to its application prospect in the future immunotherapy field

02-29

InnoModels: Introduction to the Features of iHuPBMC-B

In the field of life sciences, InnoModels Biotechnology is leading the industry with its outstanding innovation and cutting-edge technologies. Among them, iHuPBMC-B is a high-profile product of InnoModels Biotechnology, which has revolutionized scientific research with its unique features and advantages

02-28

InnoModels: iHuPBMC-T Technology, a New Solution for Cell Therapy Research

In recent years, cell therapy technology has attracted much attention worldwide, and more and more research institutes and pharmaceutical companies have devoted themselves to research and development in this field. However, the key technical bottlenecks in cell therapy research have been restricting the rapid development of this field. In this regard, InnoModels Biotechnology has independently developed an innovative technology, iHuPBMC-T, which provides a brand new solution for cell therapy research

02-28

InnoModels: MHC Humanized Mouse Models for Drug Discovery and Development

With the rapid development of modern biomedicine, there is a growing demand for animal models in drug discovery and development. In the field of humanized mouse models, MHC (major histocompatibility complex) humanized mouse models have become a research hotspot due to their high simulation of the human immune system. As a leading developer of MHC humanized mouse models in China, InnoModels Biotechnology provides efficient and accurate experimental animal models for global drug discovery and development

< 1...42 43 44...61 >

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License